Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Sunshine Biopharma (SBFM) over the last 8 years, with Sep 2025 value amounting to 1.18.

  • Sunshine Biopharma's Asset Utilization Ratio rose 5.93% to 1.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.18, marking a year-over-year increase of 5.93%. This contributed to the annual value of 1.20 for FY2024, which is 41.46% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Asset Utilization Ratio stood at 1.18, which was down 1.02% from 1.19 recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Asset Utilization Ratio high stood at 1.21 for Q1 2025, and its period low was 0.01 during Q3 2022.
  • For the 3-year period, Sunshine Biopharma's Asset Utilization Ratio averaged around 0.93, with its median value being 1.00 (2024).
  • Per our database at Business Quant, Sunshine Biopharma's Asset Utilization Ratio slumped by 85.06% in 2022 and then surged by 6,027.84% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Asset Utilization Ratio (Quarterly) stood at 0.10 in 2021, then increased by 27.67% to 0.12 in 2022, then soared by 606.75% to 0.88 in 2023, then skyrocketed by 31.33% to 1.15 in 2024, then increased by 5.93% to 1.18 in 2025.
  • Its last three reported values are 1.18 in Q3 2025, 1.19 for Q2 2025, and 1.21 during Q1 2025.